Botulinum Toxin Dilution and Endplate Targeting in Spasticity: A Double-Blind Controlled Study
Jean‐Michel Graciès(Université Paris-Est Créteil), David M. Simpson(Icahn School of Medicine at Mount Sinai), Mara Lugassy(Presbyterian Hospital), Donald J. Weisz(Mount Sinai Medical Center), Michele Vecchio(University of Catania), Steven R. Flanagan(Icahn School of Medicine at Mount Sinai)
Cited by 185
Related Papers
Pathophysiology of spastic paresis. II: Emergence of muscle overactivity
|Muscle & Nerve|2005|499
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy
|Neurology|2001|309
Short-term effects of dynamic Lycra splints on upper limb in hemiplegic patients
|Archives of Physical Medicine and Rehabilitation|2000|262